Yahoo Web Search

  1. Australian Drug Maker Jumps 51% After Winning FDA Approval

    Bloomberg via Yahoo FinanceOct 09 4:12 AM

    Shares of the Melbourne-based bio-pharmaceutical firm jumped as much as 57% in Sydney, the most since October 2014, after the U.S. allowed the use of the drug Scenesse to treat erythropoietic ...

  2. Although a report this morning suggesting HKEX was looking to take a second swing at taking over LSE was later watered down, the end of merger fever has given investors a chance to take a broader ...

  3. Bypassing an IPO Weds Strange Bedfellows in Burgers and Biotech

    Bloomberg via Yahoo FinanceOct 11 21:00 PM

    Chanticleer Holdings Inc. and Sonnet BioTherapeutics proposed a partnership to conduct what is known as a reverse merger. This would allow Chanticleer, whose restaurant brands include BGR, Just ...

  4. Amazon's cloud computing is like a "soft drug", a French minister said on Tuesday, warning that time was running out for Europe to wean itself off the U.S. company's services.

  5. Edited Transcript of CRL earnings conference call or presentation 31-Jul-19 12:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceOct 05 3:00 AM

    We believe that Charles River is a stronger company today than it's ever been. We have invested tremendous effort over time to add people and capacity to accommodate growing client demand ...

  6. Last week, WeWork owner The We Company said it was putting its plans for an IPO on ice, while entertainment and talent agency Endeavor Group Holdings pulled its listing last month. The ...

  7. German biotechnology firm BioNTech SE lowered the price range for its U.S. initial public offering (IPO) on Wednesday and said it would sell fewer shares, making it the latest company ...

  8. Edited Transcript of PBYI earnings conference call or presentation 8-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceOct 07 6:09 AM

    Based on the results of NALA trial, Puma filed a supplemental New Drug Application or sNDA for neratinib for the treatment of third line HER2-positive metastatic breast cancer in June ...

  9. Seattle Genetics and Coty rise while Boeing, McKesson fall

    Associated Press via Yahoo FinanceOct 21 20:31 PM

    The drug developer said a potential breast cancer treatment met a key study goal of improving patients' survival.

  10. Tyson Bans Pig-Fattening Drug in Bid to Target China Demand

    Bloomberg via Yahoo FinanceOct 17 19:07 PM

    “This paves the way for rapid and increasing shipments to China,” said Dennis Smith, a senior livestock analyst and broker with Archer Financial Services. Hardest hit is China, home to ...